osimertinib
astrazeneca
['adaura', 'nsclc', 'sclc', 'aura ,(-laura)']
 adaura 3 yr update of adjuvant osi vs placebo given for 3 yrs in nsclc. large dfs difference but as expected, the curves come closer together after osi ends. cure vs delay? is the clinical and financial tox worth it?
great session #esmo22 
Enjoying oncology, without meaning to sound too cynical